CD8A and neoplasm: Mechanistically it was shown that Ad-LIGHT + PSCA trivax combination therapy increased intra-tumoral CD8+ T cells and prevented the maturation and functioning of intra-tumoral Tregs, ultimately creating a more immunologically hot tumor (55).